This article was originally posted on DocwireNews ABSTRACT INTRODUCTION: : Smoldering multiple myeloma (SMM) is a clonal plasma cell (PC) disorder...
News
Higher Rates of COVID-19 Mortality for Patients with Multiple Myeloma
This article was originally posted on Docwirenews According to new data published in Blood, patients with multiple myeloma (MM) who...
Saad Z. Usmani, MD, MBA, FACP, on the Latest in Multiple Myeloma Research
This article was originally published on Cancer Network Treatment options for multiple myeloma only continued to improve over the course of 2020,...
Insurance Status Linked to Survival for Patients with Multiple Myeloma
This article was originally published on UrbanhealthToday Insurance status was found to be significantly associated with survival for patients with...
A Beginner’s Guide to Understanding Myeloma
This article was originally published on Curetoday The last 15 years have proved pivotal for patients with myeloma, as the Food and Drug...
Understanding New Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma
This article was originally published Cure There has been tremendous growth over the years in terms of treatment options for patients with multiple...
Subcut daratumumab: reducing treatment burden in myeloma
This article was originally published on The limbic Subcutaneous daratumumab with pomalidomide and dexamethasone (D-Pd) is an effective and...
Phase III Trial Supports Efficacy of Subcutaneous Daratumumab in Relapsed/Refractory Myeloma
This article was originally published on Ash Clinical News Patients with relapsed/refractory multiple myeloma (MM) who were treated with a...
Year in Review: Multiple Myeloma
This article was originally posted on MEDpage Today Despite some concern over a novel ocular toxicity, the FDA granted accelerated...
Myeloma Research Review – issue 36
Welcome to issue 36 of Multiple Myeloma Research Review. The use of ixazomib-based induction therapy in routine clinical practice is relatively...
Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies
This article was originally published on Multiple Myeloma Today ABSTRACT BACKGROUND: Patients with hematological malignancies (HM), including...
Newsletter: Summer 2020
Dear All It is nice to see the days warming up even though in Wellington we seem to be getting perpetual rain. Spare a thought for our UK brethren...